- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Liver Health Policy Update: Despite Liver Cancer Trends We Have Opportunity
October is Liver Cancer Awareness Month, an annual national awareness campaign centered around raising the voices of those impacted by liver cancer, showing the importance of liver cancer screening and prevention, and examining the future of the liver cancer landscape worldwide.
Each year tens of thousands of people hear the words “You have liver cancer” and sadly these numbers are increasing, unlike many other cancers.
The statistics are frightening and staggering, and the trends may paint a picture that seems insurmountable, but they also provide an opportunity. According to the American Cancer Society 70% of liver cancer cases could be prevented. We also know that obesity, nonalcoholic steatohepatitis (NASH), the opioid epidemic, and HBV are all critical drivers in the rise of liver cancer. A disease that is interconnected in so many ways, and known to be preventable, provides an opportunity to collaborate with our colleagues, peers, and experts in other disease states.
To answer the call of all impacted by liver cancer, we must collaborate and commit to improving liver cancer outcomes. One voice is never as effective as many united behind a single cause.
October is Liver Cancer Awareness Month, an annual national awareness campaign centered around raising the voices of those impacted by liver cancer, showing the importance of liver cancer screening and prevention, and examining the future of the liver cancer landscape worldwide.
To read more, click here.
Inside the Center's MDD Value Model and Its Use of Dynamic Pricing
May 13th 2025Larragem Raines, MS, of the Center for Innovation & Value Research, discusses the organization's major depressive disorder (MDD) open-source value model, dynamic pricing, and the future role of artificial intelligence in care.
Listen
Community Oncology Reacts to Trump's Drug Pricing Executive Order
May 2nd 2025An executive order signed on Tuesday, March 15, necessitated a change in plans for this panel discussion from the 2025 Community Oncology Conference, with the assembled experts, moderated by Ted Okon, MBA, executive director of the Community Oncology Alliance, speaking to how the order would reverberate across the community oncology space.
Read More
Advancing the Art of Medicine Through Partnership
April 29th 2025Oncology leaders from Alliance Cancer Specialists, American Oncology Network, CHI St. Vincent, Memorial Sloan Kettering Cancer Center, and New York Cancer & Blood Specialists discussed the power of collaboration in cancer care, highlighting partnerships that enhance patient outcomes and resource sharing in community practices.
Read More
